Delivery Order SPE2DB24D2018-SPE2DB25FWWB3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,313.12 on September 26, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit dose packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's ability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (quantity: 30 units) on July 17, 2025, with a completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit packaging) with a firm fixed price structure. The contract is non-competitive and competitively awarded with an ultimate completion date of July 16, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the point of delivery for this pharmaceutical product. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The award, made on September 29, 2025, with an ultimate completion date of October 21, 2025, was competitively awarded without set-aside designation under a firm fixed-price contract structure. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $8,313.12 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orgovyx 120 mg tablets (30-count units) with an ultimate completion date of October 2, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit pack) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $13,855.20 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 1, 2025, with a completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on September 22, 2025, with completion targeted for October 14, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at approximately $1...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWB3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8.31K to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) under a firm fixed price contract. This non-competitive delivery order, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a standard pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for military and federal healthcare systems, supplying an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The parent IDC enables the company to fulfill pharmaceutical requirements for various government customers, including the Defense Health Agency and U.S. Coast Guard, supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/6/25 |